Peptide Half-Lives: Minutes to Days

📅 August 3, 2026 ⏱️ 2 min read ✍️ Team TPS

Half-life decides how often you use something, and for peptides it varies by orders of magnitude, from minutes to days.

What half-life actually means

The time for half the compound to be eliminated. After one half-life, half remains; after two, a quarter. Steady state, where what goes in matches what leaves, takes roughly four to five half-lives.

That is why a long-acting compound takes weeks to show its real effect and a short-acting one works immediately.

The very short ones

Native peptides are often cleared in minutes. Ipamorelin is short-acting by design, a sharp pulse of GH release rather than sustained elevation, which is closer to natural physiology.

Native GHRH lasts minutes, which is why tesamorelin exists as a stabilised analogue.

Engineering longer ones

Most modifications exist to extend half-life. The DAC modification on CJC-1295 binds it to albumin and stretches days into a week. The LR3 modification on IGF-1 resists binding proteins and turns minutes into hours.

The GLP-1 compounds are the clearest example: semaglutide’s structure gives it a week-long half-life, which is the entire reason it is weekly rather than daily. See semaglutide vs tirzepatide vs retatrutide.

Why longer is not automatically better

A long half-life means convenience and stable levels. It also means slow onset, slow exit, and no ability to change your mind quickly.

For GH secretagogues in particular, constant elevation is arguably worse than pulses: the body’s own pattern is pulsatile, and sustained signalling can desensitise receptors. That is the argument for no-DAC over DAC.

What it means practically

Short half-life means frequent use and fast feedback. Long half-life means infrequent use and a commitment.

It also decides how long a bad reaction lasts, which is the argument for trying an unfamiliar compound in its shortest-acting form, exactly as with NPP versus deca.

Supplied for research purposes only.